Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Primary Myelofibrosis × Hydroxyurea × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia 8 Brain Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Acute 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Glioblastoma 7 Polycythemia Vera 6 Meningioma 6 Head and Neck Neoplasms 6 Gliosarcoma 5 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Congenital Abnormalities 2 Treatment-Refractory Solid Tumors 1 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thrombosis 1 Thrombocytosis 1

Interventions

Cyclophosphamide 53 fludarabine phosphate 44 ruxolitinib 37 Tacrolimus 33 Peripheral Blood Stem Cell Transplantation 33 Mycophenolic Acid 32 Busulfan 30 Whole-Body Irradiation 27 Cyclosporine 24 Antilymphocyte Serum 24 Methotrexate 22 fludarabine 20 Melphalan 17 Filgrastim 16 Radiotherapy 13 Methylprednisolone 12 Stem Cell Transplantation 11 Sirolimus 11 Etoposide 11 Cord Blood Stem Cell Transplantation 11 thymoglobulin 10 Flow Cytometry 9 Azacitidine 9 Decitabine 8 Cytarabine 8 Specimen Handling 7 Psychiatric Rehabilitation 7 Prednisone 7 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 7 navitoclax 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04217356 2026-01-26

ALLO-BAT

University Health Network, Toronto

Active not recruiting

Bone Marrow Neoplasms, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡